About
Solutions
Pipeline
Publications
News
Careers
CN
Open main menu
News
Track Our News on
2022-01-25
Chemexpress (SHA:688131) and MindRank strengthen cooperation in AI-enabled Drug Discovery
2022-01-17
MindRank begins IND-enabling studies of its first AI-designed drug, eight months after program initiation
2022-01-07
Nature BME|Amelioration of Alzheimer’s Disease Pathology by Mitophagy inducers identified via machine learning and a cross-species workflow
2021-12-15
MindRank AI has Completed Tens of Millions of US dollars in A Round financing, AI facilitates Drug Pipeline R&D
2021-10-23
MindRank AI and Medicilon Preclinical Research LLC (SHA: 688202) Reached a Strategic Cooperation to Develop Innovative Cancer Drugs with AI
2021-09-23
Interview with EY: Experts from China and Abroad Talk about AI Drug Discovery (part Ⅱ)
2021-09-15
MindRank AI was Invited to Join the “NVIDIA Startup Acceleration Program”
2021-09-15
Interview with EY: Experts from China and Abroad Talk about AI Drug Discovery (part Ⅰ)
2021-08-10
MindRank AI and Antengene (6996.HK) Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets
2021-08-05
MindRank AI and HaoYuan Chemexpress (SHA: 688131) Establish Strategic Colleboration to Develop AI-assisted Chemical Synthesis Platform
2021-06-10
MindRank AI Win the Championship in the Global Artificial Intelligence Technology Innovation Contest
2021-05-24
MindRank AI completed tens of millions of angel round financing, Sherpa Medical Fund led the investment
Previous
4 / 4
Next
Previous
4 / 4
Next